Home-Based Exercise for Adults Living With Overweight and Obesity
ConditionOverweight and Obesity
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-64
SponsorCoventry University
About this trial
The study aims to implement a 12-week home-based exercise programme utilising an online intervention delivery platform. The focus will be on increasing exercise behaviour within the participant's home setting using aerobic, resistance and flexibility exercises as well as behaviour change techniques. Following the programme, semi-structured interviews will be conducted, to explore participant experiences.
It is hypothesised that the exercise programme will be feasible, accessible and acceptable.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
BMI ≥25kg/m² or BMI ≥30kg/m²
English speaking
Able to follow visual and verbal instructions
Access to the internet and accompanying technology (e.g. laptop or tablet)
Disqualifiers
Unable to provide informed consent
Receiving invasive medical treatment or planned surgery preceding to, or during, the programme
Severe mental or physical limitations precluding participation safely in the home environment
No access to the internet and/or facilitative technology such as a laptop or tablet
Trial design
Design model
Parallel
Treatments tested in this trial
Home-based exercise programme
BehavioralA 12 week, online delivered, home-based exercise programme.
Treatment groups
30 Participants
are divided into 2 treatment groupsGroup A: Exercise InterventionExperimental treatment 1 intervention
Group B: Waitlist ControlNo intervention 0 interventions
Trial outcomes
Primary outcomes
1
Feasibility and acceptability of the programme through recruitment rate
Recruitment rate will be calculated by dividing the number of eligible candidates by the number who consent to participate.
Time frame
Calculated at trial end, i.e.12 weeks after inclusion.2
Feasibility and acceptability of the programme through attrition
Attrition rate will be defined and calculated as discontinuation of the intervention without return.
Time frame
Calculated at trial end, i.e. 12 weeks after inclusion.3
Feasibility and acceptability of the programme through adherence
Adherence will calculated by monitoring the online platform engagement and outputs from post exercise session questionnaires.
Time frame
Calculated at trial end, i.e. 12 weeks after inclusion.4
Feasibility and acceptability of the programme through intervention engagement
Engagement will be calculated by monitoring participant's activity on the online platform.
Time frame
Calculated at trial end, i.e. 12 weeks after inclusion.Secondary outcomes
1
Participant Body Mass (kg)
Participant Body Mass will be measured using calibrated, digital scales.
Time frame
Taken at baseline, 6 weeks and 12 weeks/programme completion.2
Participant Body Fat Mass (kg)
Participant Body Fat Mass will be measured using the BiodyXpertZMII.
Time frame
Taken at baseline, 6 weeks and 12 weeks/programme completion.3
Participant Body Fat Percentage (%)
Participant Body Fat Percentage will be measured using the BiodyXpertZMII.
Time frame
Taken at baseline, 6 weeks and 12 weeks/programme completion.4
Participant Fat Free Mass (%)
Participant Fat Free Mass will be measured using the BiodyXpertZMII.
Time frame
Taken at baseline, 6 weeks and 12 weeks/programme completion.Other outcomes
1
Functional Ability (aerobic capacity and endurance) change through Six Minute Walk test
This will be measured using the Six Minute Walk test and change will be compared within and between participants.
Time frame
Taken at baseline and 12 weeks/programme completion.2
Functional Ability (leg strength and endurance) change through 30s Sit to Stand test
This will be measured using the 30s Sit to Stand test and change will be compared within and between participants.
Time frame
Taken at baseline and 12 weeks/programme completion.3
Functional Ability (strength) change through hand grip strength test
This will be measured using the hand grip dynamometer, and change will be compared within and between participants.
Time frame
Taken at baseline and 12 weeks/programme completion.4
Quality of Life and Cost Effectiveness
This will be measured using the European Quality of Life Five Dimension Questionnaire (EQ-5D-5L), and change will be compared within and between participants. Scores range from 1-5 with lower scores associated with a better outcome.
Time frame
Taken at baseline, 6 weeks and 12 weeks/programme completion.Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: